Roger Franklin

Roger Franklin is a Partner at Hadean Ventures, where Roger has been working since November 2018. Prior to this role, Roger worked as a Senior Analyst in Pharmaceuticals and Biotech at Liberum from August 2015 to November 2018. Roger also has experience as a Senior Associate in Corporate strategy & private equity at PwC Strategy from September 2007 to September 2010. Roger holds a PhD in Molecular Genetics from the University of Cambridge and a MBiochem in Biochemistry from the University of Oxford.